PR

A delegation of EU member states, representatives of the Council of the EU and the Ministry of Education,Youth and Sports visited the research infrastructures at the BIOCEV center

22. 07. 2022 Information News PR

On July 21, 2022, a delegation of representatives of the Council of the EU and the Ministry of Education, Youth and Sports visited the BIOCEV, a joint centre of the Czech Academy of Sciences and Charles University in Vestec near Prague. The goal was to present large research infrastructures and their potential for collaboration in…

AV21 Centre for Preclinical Testing: The path form the test tube to the patients

15. 07. 2022 Information News PR Service

To test substances that have succeeded in basic research and help them on the long journey from the test tube to the development of new drugs. This is the goal of the Centre for Preclinical Testing, funded by the Strategy of the Czech Academy of Sciences AV21. The centre is run in close collaboration of…

Radislav Sedlacek participated in the panel discussion at EU-AMRI launch event

14. 04. 2022 News PR

“Research infrastructures are perfectly positioned to co-work at the frontier of science and industry.”, said Radislav Sedlacek, Director of the Czech Centre for Phenogenomics and the former Chair of the ESFRI Health and Food Strategic Working Group at the EU-AMRI launch event, which took place on 5th April 2022 in Brussels. You can watch the…

Towards precision medicine and gene therapy – a new AV21 Strategy programme

01. 03. 2022 Information News PR

Czech Centre for Phenogenomics is coordinating a new research programme “Towards precision medicine and gene therapy” of the AV21 Strategy. Our programme benefits from the synergistic expertise of all partners and creates a multidisciplinary consortium covering the areas of gene editing, organic chemistry of nucleic acid delivery systems, preclinical models of human diseases, and starting with neurosciences…

CCP talk at final PATHBIO meeting

06. 12. 2021 News PR

Radislav Sedlacek shared experience of the Czech Centre for Phenogenomics in preclinical development in his talk “Beyond standardized phenotyping pipeline: the path towards preclinical development” at the final PATHBIO meeting “Reproducibility and Translatability in Research: the Path forward”. The meeting took place on 3rd December, 2021 in Naples. The meeting was opened by a keynote…

Three CCP members joined COST Actions

06. 10. 2021 News PR

Jan Rozman joined the new COST Action CA20135 – Improving biomedical research by automated behaviour monitoring in the animal home-cage. The Action will assess the potential of these technologies, develop user guidelines and standard operating procedures and identify needs for further technological development. CCP will bring knowledge in preclinical testing in the stroke research field…

Taipei Economic and Cultural Office visited CCP

20. 07. 2021 News PR

CCP introduced its research and services to the representatives of the Taipei Economic and Cultural Office in Prague on 19th July 2021. We discussed the possible areas of collaboration with the research institutes and industry from Taiwan. We look forward to collaborate in the future.

Visit of Central Bohemian government to CCP

16. 07. 2021 Information PR

The Governor of the Central Bohemian Region Petra Pecková, Regional Council Member for the Environment Jana Skopalíková, and Regional Council Member for Health Pavel Pavlík visited the Czech Centre for Phenogenomics during their visit of BIOCEV, the joint research campus of the Czech Academy of Sciences and Charles University in Vestec near Prague, on 14th…

ESFRI Open Session on response to COVID-19 pandemic

29. 03. 2021 News PR

The 75th ESFRI Forum Plenary was held virtually on 23rd – 24th March 2021. The first Open Session organised as a part of the ESFRI meeting brought together the ESFRI Delegates and representatives of the ESFRI Research Infrastructures to discuss the response to the COVID-19 pandemic. The main focus was put on the activities of…

CCP celebrates the Rare Disease Day 2021

26. 02. 2021 News PR

The CCP primary goal is to perform excellent research. In the period 2021 – 2030, together with other foreign centers gathered in the International Mouse Phenotyping Consortium we plan  to deliver jointly broad-based genomic insights into the function of human genetic variation in both coding and non-coding sequences that underpin future developments in precision medicine,…